By David Cassak
Those currently enjoying venture capitalists' renewed interest in medical device companies may be tempted to forget that through the last half of the 1990s, financing opportunities for medical device start-ups grew despairingly thin. Burned by the Class of '96--a group of device start-ups that went public early and almost universally failed to meet expectations--public investors all but closed their doors to small medical device plays
Read the full article – start your free trial today!
Join thousands of industry professionals who rely on Medtech Insight for daily insights
- Start your 7-day free trial
- Explore trusted news, analysis, and insights
- Access comprehensive global coverage
- Enjoy instant access – no credit card required
Already a subscriber?